The predictive capability of the nine-gene panel was more significant than those of traditional indicators (Figure 4A) in terms of tumor size, lymph node metastasis, and ER/PR and HER2 statuses, especially for TNBC and Her2-positive BRCA subtypes. Here, ERBB2 is linked to neoplasm.